Prime People PLC
17 May 2005
Prime People plc ('the Company')
Surrender of share options granted under The Prime People 2001 Employee Share
Option Scheme and adoption of an Enterprise Management Incentive Share Option
Scheme
The Prime People 2001 Employee Share Option Scheme
Christopher Heayberd, finance director, has surrendered 547,238 options granted
to him under the existing Inland Revenue Approved share option scheme.
Enterprise Management Incentive Share Option Scheme
The company announce the adoption of an Enterprise Management Incentive Share
Option Scheme.
Simon Murphy who was appointed chief executive of the company yesterday, has
been granted an option over 1,842,335 Ordinary Shares at an exercise price of
Nil pence per share subject to the rules of the scheme.
Christopher Heayberd, finance director, has been granted an option over
1,842,335 Ordinary Shares at an exercise price of Nil pence per share subject
to the rules of the scheme.
Contact:
Chris Heayberd
0207 831 5297
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.